UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
80.00
0.00 (0.00%)
At close: Mar 24, 2026

UnicoCell Biomed Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-114.84-93.07-84.11-91.16-86.37
Depreciation & Amortization
20.2627.2526.1824.0925.53
Other Amortization
0.290.330.210.180.74
Loss (Gain) From Sale of Assets
---4.83--
Loss (Gain) From Sale of Investments
0.671.79---
Stock-Based Compensation
5.121.391.822.962.26
Provision & Write-off of Bad Debts
0.1200--
Other Operating Activities
1.29-1.25-3.42-0.070.29
Change in Accounts Receivable
-0.5-0.73-0.7-0.980.36
Change in Inventory
-0.62-2.330.72-0.07-2.1
Change in Accounts Payable
-0.751.87-0.810.84-0.4
Change in Unearned Revenue
-5.526.6-1.511.52-
Change in Other Net Operating Assets
3.17-3.360.9-0.92-2.02
Operating Cash Flow
-91.31-61.52-65.55-63.6-61.71
Capital Expenditures
-5.5-5.32-15.8-14.45-23.64
Sale of Property, Plant & Equipment
--6.16--
Sale (Purchase) of Intangibles
-0.23-0.38-0.18-0.16-0.36
Investment in Securities
-167.9-117.35-297.14-150.08-0.08
Other Investing Activities
0.140.71-0.24-0.30.27
Investing Cash Flow
-173.49-122.35-307.2-164.99-23.8
Long-Term Debt Repaid
-6.22-6.09-6.04-7.82-9.37
Net Debt Issued (Repaid)
-6.22-6.09-6.04-7.82-9.37
Issuance of Common Stock
302.29179.85344.88159.043.71
Other Financing Activities
--0.220.170.15-
Financing Cash Flow
296.07173.54339.01151.38-5.66
Net Cash Flow
31.27-10.33-33.74-77.21-91.17
Free Cash Flow
-96.81-66.84-81.35-78.05-85.34
Free Cash Flow Margin
-321.59%-209.66%-330.82%-542.15%-1043.70%
Free Cash Flow Per Share
-1.59-1.17-1.51-1.88-2.27
Cash Interest Paid
1.341.461.451.260.66
Cash Income Tax Paid
0.230.720.240.020.04
Levered Free Cash Flow
-67.64-44.47-54.17-49.26-54.15
Unlevered Free Cash Flow
-66.8-43.56-53.27-48.47-53.74
Change in Working Capital
-4.222.05-1.40.39-4.16
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.